Additionally, Jardiance is FDA approved for the following uses: To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure To reduce the risk of hospitalization, kidney complications, and cardiovascular death in adults with chronic kidney disease The active ingredient in Victoza, liraglutide, can also be found in a medication called Saxenda
High obesity and type 2 diabetes prevalence further fuel market growth
The goal is finding your optimal dosethe one where weight loss is consistent and side effects feel tolerablenot necessarily reaching the highest dose available
References: Monnier, M., Duds, B., & Prochiantz, A
When tirzepatide is administered, GLP-1 receptors in the brain are activated, signaling fullness and satisfication earlier